The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

NCT01980940 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Organon and Co